According to the USFDA, the labels on Patanjali’s two sharbat bottles, sold within India, were found to be having “additional medicinal and dietary market claims” as compared to the ones meant for export to America. They also found out that the production and packaging area for exported products is separate from the domestic products.
The US food safety regulations are more stringent than Indian laws. If the company is found to be guilty of selling misbranded product in US, the USFDA can issue them a warning letter and can take serious actions like seize of whole batch, stopping the import, huge fine and even imprisonment of company officials.
Unit Ⅲ of Haridwar plant of Patanjali Ayurved Ltd. was inspected by the USFDA inspector last year. The inspector observed pigeons flying above the production equipment during Honey manufacturing. It was noticed that the production and packaging area is separate for Digestif manufacturing for export and domestic market. Inspector also found out that the firm’s laboratory personnel and batch records only “appear to follow” written operating procedures as they were not in operating mode during inspection.
Corrective actions should be followed by the company to avoid the USFDA actions.
Mr Vinod Arora, Principal Advisor, IGMPI
Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like